These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16756968)

  • 1. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Lee CY; Chou MC; Lu KH
    Clin Chim Acta; 2006 Oct; 372(1-2):167-72. PubMed ID: 16756968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
    Yang SF; Hsieh YS; Lue KH; Chu SC; Chang IC; Lu KH
    Clin Biochem; 2008 Jan; 41(1-2):109-16. PubMed ID: 17996201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
    J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Li TJ; Lu KH
    Clin Chim Acta; 2008 Jan; 387(1-2):90-6. PubMed ID: 17963739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement.
    Hsieh YS; Yang SF; Chu SC; Chen PN; Chou MC; Hsu MC; Lu KH
    Arthroscopy; 2004 May; 20(5):482-8. PubMed ID: 15122138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Wu CL; Lu KH
    Connect Tissue Res; 2004; 45(3):142-50. PubMed ID: 15512768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
    Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
    Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway.
    Hung SH; Shen KH; Wu CH; Liu CL; Shih YW
    J Agric Food Chem; 2009 Feb; 57(4):1291-8. PubMed ID: 19178296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator and receptor in osteoarthritis.
    Serni U; Fibbi G; Anichini E; Zamperini A; Pucci M; Mannoni A; Matucci A; Benucci M; Del Rosso A; Del Rosso M
    J Rheumatol Suppl; 1995 Feb; 43():120-2. PubMed ID: 7752114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone.
    Bao JP; Chen WP; Feng J; Zhao J; Shi ZL; Huang K; Wu LD
    Clin Chim Acta; 2009 Oct; 408(1-2):1-7. PubMed ID: 19589338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis].
    Xu HT; Chen Y; Chen LK; Li JY; Zhang W; Wu B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):47-52. PubMed ID: 18245904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlation with the PA/plasmin system in septic arthritis of the knee.
    Hsieh YS; Yang SF; Lue KH; Lu KH
    Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.